Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

April 29, 2016

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Basal Cell Carcinoma
Trial Locations (1)

45122

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (Universitätsklinikum Essen), Essen

All Listed Sponsors
collaborator

OnkoDataMed GmbH

INDUSTRY

lead

University Hospital, Essen

OTHER

NCT02781389 - Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions | Biotech Hunter | Biotech Hunter